CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for China Medicine Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

China Medicine Corporation
Guangri Tower
Suite 702, No. 8 Siyou South 1St Street
Phone: +86 2087391718p:+86 2087391718 GUANGZHOU, GNG  510600  China Ticker: CHME CHME
This company ceased filing statements with the SEC on 10/4/2012.
Business Summary
China Medicine Corporation is a pharmaceutical company. The Company is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The Company's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The Company also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201012/31/2009YesYes---

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
6770 Blank checks
5047 Medical, dental, and hospital equipment and supplies
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director SenshanYang 50 2/10/2006 2/8/2006
Chief Financial Officer, Vice President - Finance and Accounting Chi FungHo 40 11/16/2010 11/16/2010
Executive Vice President MinhuaLiu 41 9/30/2011 2/8/2006
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Bioengineering Co., Ltd.
CHME
Guangzhou Co-win
4 additional Business Names available in full report.

General Information
Number of Employees: 281 (As of 12/31/2009)
Outstanding Shares: 27,837,970 (As of 12/31/2018)
Shareholders: 40
Stock Exchange: OTC
Federal Tax Id: 510539830


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023